Scopus BioPharma (SCPS) executive Lamstein bought 500 shares for $4,670 at $9.34
Stocks in this Quantisnow insightHealth Care
Insider transactions reported
Joshua R Lamstein (executive at Scopus BioPharma Inc., SCPS) reported that they bought 500 shares for $4,670 at $9.34 on Feb 23, 2021. After these transactions the filing shows 117,297 shares held directly.
- Reporting person
- Lamstein Joshua R
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Feb 23, 2021 | Open-market purchase (P) | Common Stock, par value $0.0011 | +500 | $9.34 | $4,670 | 117,297 direct |
Holdings before and after
- Common Stock, par value $0.001: 116,797 to 117,297 direct
Footnotes from the filing
- 1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.19 to $9.55 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.
Transaction codes in this filing
- Open-market purchase:
- Code P marks a purchase in the open market or a private deal. The insider paid for these securities.
FAQ
What did Lamstein report in this SCPS Form 4?
Joshua R Lamstein (executive at Scopus BioPharma Inc., SCPS) reported that they bought 500 shares for $4,670 at $9.34 on Feb 23, 2021. After these transactions the filing shows 117,297 shares held directly.
How many SCPS shares does Lamstein hold after this filing?
The filing shows 117,297 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code P mean on an SEC Form 4?
Code P marks a purchase in the open market or a private deal. The insider paid for these securities.
Historical context for SCPS
Earlier insider filings at SCPS
- Feb 24, 2021SEC Form 4: Scott Ira Greenspan bought $14,474 worth of Common Stock (1,500 units at $9.65), increasing ownership by 0.25% to 80,675 units
- Feb 23, 2021SEC Form 4: R Joshua Lamstein bought $999 worth of Common Stock (100 units at $9.99), increasing ownership by 0.09% to 116,797 units
- Feb 23, 2021SEC Form 4: Scott Ira Greenspan bought $4,522 worth of Common Stock (450 units at $10.05)
- Feb 19, 2021SEC Form 4: R Joshua Lamstein bought $5,465 worth of Common Stock (500 units at $10.93), increasing ownership by 0.43% to 116,697 units
- Feb 19, 2021SEC Form 4: Scott Ira Greenspan bought $54,153 worth of Common Stock (5,375 units at $10.07), increasing ownership by 0.59% to 80,475 units
Quantisnow market dataNASDAQ
SCPS
Scopus BioPharma Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2020
Get push alerts for SCPS
Full SCPS profile on Quantisnow Follow SCPS and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time